OCC 7.04% 66.0¢ orthocell limited

Ann: Trading Halt, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,213 Posts.
    lightbulb Created with Sketch. 1458
    I wonder if this is related:

    Characterisation of ovine bone marrow-derived stromal cells (oBMSC) and evaluation of chondrogenically induced micro-pellets for cartilage tissue repair in vivo
    https://stemcellres.biomedcentral.com/articles/10.1186/s13287-020-02045-3

    Engineered constructs were assembled during the surgery using a mould to cast a 6-mm diameter by 1.5 mm deep layer of micro-pellets, set with Baxter Tisseel fibrin glue, on a CelGro™ collagen scaffold, and fixed in place with sutures. The pilot study was terminated 8 weeks later, and defect infill was characterised via histology.
    Last edited by jcurve: 12/01/21
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.